The global Cancer Supportive Care Drugs market was valued at US$ 23800 million in 2022 and is projected to reach US$ 28330 million by 2029, at a CAGR of 2.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Supportive drugs are not anticancer drugs. They protect certain cells or organs from the side effects of chemotherapy drugs or radiation therapy.
This report aims to provide a comprehensive presentation of the global market for Cancer Supportive Care Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Supportive Care Drugs. This report contains market size and forecasts of Cancer Supportive Care Drugs in global, including the following market information:
- Global Cancer Supportive Care Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global top five companies in 2022 (%)
Increasing uptake of biosimilars, rising expenditure on healthcare, and availability of effective treatment methods, including target specific and tailored treatments are anticipated to drive the growth.
We surveyed the Cancer Supportive Care Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Supportive Care Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cancer Supportive Care Drugs Market Segment Percentages, by Type, 2022 (%)
G-CSFs (Granulocyte-colony Stimulating Factors)
ESAs (Erythropoiesis Stimulating Agents)
Anti-emetics
Bisphosphonates
Opioids
NSAIDs
Global Cancer Supportive Care Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cancer Supportive Care Drugs Market Segment Percentages, by Application, 2022 (%)
Chemotherapy Therapy
Radiation Therapy
Global Cancer Supportive Care Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cancer Supportive Care Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Supportive Care Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cancer Supportive Care Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Johnson & Johnson
Merck
Roche
Helsinn Healthcare
Heron Pharma
Tesaro
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Supportive Care Drugs, market overview.
Chapter 2: Global Cancer Supportive Care Drugs market size in revenue.
Chapter 3: Detailed analysis of Cancer Supportive Care Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Supportive Care Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Supportive Care Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Supportive Care Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Supportive Care Drugs Overall Market Size
2.1 Global Cancer Supportive Care Drugs Market Size: 2022 VS 2029
2.2 Global Cancer Supportive Care Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Supportive Care Drugs Players in Global Market
3.2 Top Global Cancer Supportive Care Drugs Companies Ranked by Revenue
3.3 Global Cancer Supportive Care Drugs Revenue by Companies
3.4 Top 3 and Top 5 Cancer Supportive Care Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer Supportive Care Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Supportive Care Drugs Players in Global Market
3.6.1 List of Global Tier 1 Cancer Supportive Care Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Supportive Care Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Supportive Care Drugs Market Size Markets, 2022 & 2029
4.1.2 G-CSFs (Granulocyte-colony Stimulating Factors)
4.1.3 ESAs (Erythropoiesis Stimulating Agents)
4.1.4 Anti-emetics
4.1.5 Bisphosphonates
4.1.6 Opioids
4.1.7 NSAIDs
4.2 By Type - Global Cancer Supportive Care Drugs Revenue & Forecasts
4.2.1 By Type - Global Cancer Supportive Care Drugs Revenue, 2018-2023
4.2.2 By Type - Global Cancer Supportive Care Drugs Revenue, 2024-2029
4.2.3 By Type - Global Cancer Supportive Care Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Supportive Care Drugs Market Size, 2022 & 2029
5.1.2 Chemotherapy Therapy
5.1.3 Radiation Therapy
5.2 By Application - Global Cancer Supportive Care Drugs Revenue & Forecasts
5.2.1 By Application - Global Cancer Supportive Care Drugs Revenue, 2018-2023
5.2.2 By Application - Global Cancer Supportive Care Drugs Revenue, 2024-2029
5.2.3 By Application - Global Cancer Supportive Care Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer Supportive Care Drugs Market Size, 2022 & 2029
6.2 By Region - Global Cancer Supportive Care Drugs Revenue & Forecasts
6.2.1 By Region - Global Cancer Supportive Care Drugs Revenue, 2018-2023
6.2.2 By Region - Global Cancer Supportive Care Drugs Revenue, 2024-2029
6.2.3 By Region - Global Cancer Supportive Care Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer Supportive Care Drugs Revenue, 2018-2029
6.3.2 US Cancer Supportive Care Drugs Market Size, 2018-2029
6.3.3 Canada Cancer Supportive Care Drugs Market Size, 2018-2029
6.3.4 Mexico Cancer Supportive Care Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer Supportive Care Drugs Revenue, 2018-2029
6.4.2 Germany Cancer Supportive Care Drugs Market Size, 2018-2029
6.4.3 France Cancer Supportive Care Drugs Market Size, 2018-2029
6.4.4 U.K. Cancer Supportive Care Drugs Market Size, 2018-2029
6.4.5 Italy Cancer Supportive Care Drugs Market Size, 2018-2029
6.4.6 Russia Cancer Supportive Care Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Cancer Supportive Care Drugs Market Size, 2018-2029
6.4.8 Benelux Cancer Supportive Care Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer Supportive Care Drugs Revenue, 2018-2029
6.5.2 China Cancer Supportive Care Drugs Market Size, 2018-2029
6.5.3 Japan Cancer Supportive Care Drugs Market Size, 2018-2029
6.5.4 South Korea Cancer Supportive Care Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Cancer Supportive Care Drugs Market Size, 2018-2029
6.5.6 India Cancer Supportive Care Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer Supportive Care Drugs Revenue, 2018-2029
6.6.2 Brazil Cancer Supportive Care Drugs Market Size, 2018-2029
6.6.3 Argentina Cancer Supportive Care Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Supportive Care Drugs Revenue, 2018-2029
6.7.2 Turkey Cancer Supportive Care Drugs Market Size, 2018-2029
6.7.3 Israel Cancer Supportive Care Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer Supportive Care Drugs Market Size, 2018-2029
6.7.5 UAE Cancer Supportive Care Drugs Market Size, 2018-2029
7 Cancer Supportive Care Drugs Companies Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Cancer Supportive Care Drugs Major Product Offerings
7.1.4 Amgen Cancer Supportive Care Drugs Revenue in Global Market (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Cancer Supportive Care Drugs Major Product Offerings
7.2.4 Johnson & Johnson Cancer Supportive Care Drugs Revenue in Global Market (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Cancer Supportive Care Drugs Major Product Offerings
7.3.4 Merck Cancer Supportive Care Drugs Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Roche
7.4.1 Roche Company Summary
7.4.2 Roche Business Overview
7.4.3 Roche Cancer Supportive Care Drugs Major Product Offerings
7.4.4 Roche Cancer Supportive Care Drugs Revenue in Global Market (2018-2023)
7.4.5 Roche Key News & Latest Developments
7.5 Helsinn Healthcare
7.5.1 Helsinn Healthcare Company Summary
7.5.2 Helsinn Healthcare Business Overview
7.5.3 Helsinn Healthcare Cancer Supportive Care Drugs Major Product Offerings
7.5.4 Helsinn Healthcare Cancer Supportive Care Drugs Revenue in Global Market (2018-2023)
7.5.5 Helsinn Healthcare Key News & Latest Developments
7.6 Heron Pharma
7.6.1 Heron Pharma Company Summary
7.6.2 Heron Pharma Business Overview
7.6.3 Heron Pharma Cancer Supportive Care Drugs Major Product Offerings
7.6.4 Heron Pharma Cancer Supportive Care Drugs Revenue in Global Market (2018-2023)
7.6.5 Heron Pharma Key News & Latest Developments
7.7 Tesaro
7.7.1 Tesaro Company Summary
7.7.2 Tesaro Business Overview
7.7.3 Tesaro Cancer Supportive Care Drugs Major Product Offerings
7.7.4 Tesaro Cancer Supportive Care Drugs Revenue in Global Market (2018-2023)
7.7.5 Tesaro Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Supportive Care Drugs Market Opportunities & Trends in Global Market
Table 2. Cancer Supportive Care Drugs Market Drivers in Global Market
Table 3. Cancer Supportive Care Drugs Market Restraints in Global Market
Table 4. Key Players of Cancer Supportive Care Drugs in Global Market
Table 5. Top Cancer Supportive Care Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cancer Supportive Care Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cancer Supportive Care Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cancer Supportive Care Drugs Product Type
Table 9. List of Global Tier 1 Cancer Supportive Care Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Supportive Care Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cancer Supportive Care Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cancer Supportive Care Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cancer Supportive Care Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cancer Supportive Care Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cancer Supportive Care Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cancer Supportive Care Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cancer Supportive Care Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cancer Supportive Care Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cancer Supportive Care Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cancer Supportive Care Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cancer Supportive Care Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cancer Supportive Care Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cancer Supportive Care Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cancer Supportive Care Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Amgen Company Summary
Table 31. Amgen Cancer Supportive Care Drugs Product Offerings
Table 32. Amgen Cancer Supportive Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Amgen Key News & Latest Developments
Table 34. Johnson & Johnson Company Summary
Table 35. Johnson & Johnson Cancer Supportive Care Drugs Product Offerings
Table 36. Johnson & Johnson Cancer Supportive Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Johnson & Johnson Key News & Latest Developments
Table 38. Merck Company Summary
Table 39. Merck Cancer Supportive Care Drugs Product Offerings
Table 40. Merck Cancer Supportive Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Merck Key News & Latest Developments
Table 42. Roche Company Summary
Table 43. Roche Cancer Supportive Care Drugs Product Offerings
Table 44. Roche Cancer Supportive Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Roche Key News & Latest Developments
Table 46. Helsinn Healthcare Company Summary
Table 47. Helsinn Healthcare Cancer Supportive Care Drugs Product Offerings
Table 48. Helsinn Healthcare Cancer Supportive Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Helsinn Healthcare Key News & Latest Developments
Table 50. Heron Pharma Company Summary
Table 51. Heron Pharma Cancer Supportive Care Drugs Product Offerings
Table 52. Heron Pharma Cancer Supportive Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Heron Pharma Key News & Latest Developments
Table 54. Tesaro Company Summary
Table 55. Tesaro Cancer Supportive Care Drugs Product Offerings
Table 56. Tesaro Cancer Supportive Care Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Tesaro Key News & Latest Developments
List of Figures
Figure 1. Cancer Supportive Care Drugs Segment by Type in 2022
Figure 2. Cancer Supportive Care Drugs Segment by Application in 2022
Figure 3. Global Cancer Supportive Care Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cancer Supportive Care Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cancer Supportive Care Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Supportive Care Drugs Revenue in 2022
Figure 8. By Type - Global Cancer Supportive Care Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cancer Supportive Care Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cancer Supportive Care Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cancer Supportive Care Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cancer Supportive Care Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cancer Supportive Care Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cancer Supportive Care Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cancer Supportive Care Drugs Revenue Market Share, 2018-2029
Figure 16. US Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cancer Supportive Care Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cancer Supportive Care Drugs Revenue Market Share, 2018-2029
Figure 28. China Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cancer Supportive Care Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cancer Supportive Care Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cancer Supportive Care Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Amgen Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Johnson & Johnson Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Roche Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Helsinn Healthcare Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Heron Pharma Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Tesaro Cancer Supportive Care Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
